Fortress Biotech (FBIO) Assets Average (2011 - 2026)

Fortress Biotech's Assets Average history runs 15 years deep, the most recent figure standing at $183.5 million for Q4 2025.

• In Q4 2025, Assets Average rose 35.25% year-over-year to $183.5 million; the TTM figure through Dec 2025 stood at $183.5 million (up 35.25% YoY), while the FY2025 annual figure was $164.9 million, up 5.78% from the prior year.
• Assets Average for Q4 2025 stood at $183.5 million, up from $170.7 million in the prior quarter.
• The five-year high for Assets Average was $402.2 million in Q1 2022, with the low at $135.7 million in Q4 2024.
• The 5-year median for Assets Average is $190.9 million (2021), against an average of $235.7 million.
• The sharpest annual moves came in 2022 and 2023: Assets Average soared 94.56% in 2022, then tumbled 51.82% in 2023.
• Fortress Biotech's Assets Average stood at $402.2 million in 2021, then declined by 23.18% to $308.9 million in 2022, then tumbled by 48.52% to $159.0 million in 2023, then decreased by 14.7% to $135.7 million in 2024, then surged by 35.25% to $183.5 million in 2025.
• Business Quant data shows FBIO's Assets Average at $183.5 million in Q4 2025, $170.7 million in Q3 2025, and $169.0 million in Q2 2025.